The Business Research Company’s global market reports are now updated with the latest market sizing
Read More
The Kidney Cancer Drugs market size is expected to reach $10.82 billion in 2030 at a CAGR of 5.1%, driven by rising renal cancer incidence.
Read More
The Ketone Supplements market size is expected to reach $10.23 billion in 2030 at a CAGR of 9.8%, driven by growing health-conscious population.
Read More
The global Ketolides market size is expected to reach $4.24 billion in 2030 at a CAGR of 5.2%, driven by rising infectious diseases.
Read More
The Janus Kinases (JAKs) Inhibitor Drug market size is expected to reach $11.04 billion in 2030 at a CAGR of 11.4%, driven by rising autoimmune diseases.
Read More
The Janus Kinase (JAK) Inhibitors market size is expected to reach $56.78 billion in 2030 at a CAGR of 19.5%, driven by rising autoimmune diseases.
Read More
The Isovaleric Acidemia (IVA) Treatment market size is expected to reach $0.83 billion in 2030 at a CAGR of 5.7%, driven by rising metabolic disorder prevalence.
Read More
The global Isotretinoin Drugs market size is expected to reach $1.7 billion in 2030 at a CAGR of 4.7%, driven by rising skin cancer cases.
Read More
The Isocitrate Dehydrogenase (IDH) Inhibitors market size is expected to reach $8.02 billion in 2030 at a CAGR of 26.6%, driven by rising acute myeloid leukemia cases.
Read More
The Ischemic Heart Disease (IHD) Drugs market size is expected to reach $7.99 billion in 2030 at a CAGR of 3.7%, driven by rising heart failure cases.
Read More
The Ipatasertib market size is expected to reach $1.6 billion in 2030 at a CAGR of 13.1%, driven by rising cancer prevalence.
Read More